Mind-body Medicine for Patients With Malignant Hematological Diseases

NCT03735992 · tracked via the Priya Life Science Germany tracker

Sponsor

Universität Duisburg-Essen

Phase

Not applicable

Started

2017-09-06

Last updated

2026-04-15

Condition(s) studied

Hematologic Neoplasms

Investigational drug(s) / intervention(s)

Mind-body medicine group program

Mind-body medicine group program: The group program is mainly based on MBSR. It further integrates elements of the mind-body medicine cancer program of the Benson-Henry Mind/Body Medical Institute at Harvard Medical School which is rooted in psychoneuroendocrinology and focuses on relaxation techniques, exercise, cognitive restructuring, diet, and social support. In addition, naturopathic methods of selfregulation and self-care are incorporated.

Study summary

This randomized controlled trial aims to investigate the effectiveness of a mind-body group program as a supprtivemanagement strategy for fatigue in patients with malignant hematological diseases.

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * Patients with malignant hematological diseases in complete remission after primary chemotherapy and/or radiation * Physical and mental ability to attent 8 of 11 group units Exclusion Criteria: * Chemotherapy, radiation, or rehabilitation programm during the study period * Pregnancy * Participation in other studies with behavioral interventions during the study period

Primary outcome measure(s)

General Fatigue — week 12
Multidimensional Fatigue Inventory (MFI) - General Fatigue Subscale

Trial sites (1)

Facility	City	Region	Status
Robert-Bosch-Krankenhaus, Abteilung für Hämatologie, Onkologie und Palliativmedizin	Stuttgart	Germany	Recruiting

More Universität Duisburg-Essen trials in Germany

Mild Water-filtered Infrared-A Whole-body Hyperthermia in Patients With Post-COVID Syndrome (HyPoCo) Active, not recruiting

Wild Blueberries in Colitis Recruiting

Hypoglossal Acupuncture for Dysgeusia in Patients Undergoing Chemotherapy Recruiting

Resistance Profiling Using Functional Imaging and Next Generation Sequencing in Refractory Gastrointestinal Stomal Tumors (GIST) Starting soon

Reducing Symptom Burden Through Physical Exercise in Melanoma Patients Recruiting

Other trials for the same condition

LLM-Generated Plain-Language Patient Synopses to Improve Comprehension in Hematology and Oncology (oncOPAL) Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03735992 on ClinicalTrials.gov ↗ ← All trials in Germany